Skip to content

Randomized comparison of two contemporary balloon devices in catheter ablation of atrial fibrillation - Cryoballoon versus Laserballon II

Randomized comparison of two contemporary balloon devices in catheter ablation of atrial fibrillation - Cryoballoon versus Laserballon II

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012423
Enrollment
200
Registered
2017-06-09
Start date
2017-05-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.0 I48.1

Interventions

Group 1: pulmonary vein isolation with Cryoballoon (catheter ablation) Group 2: pulmonary vein isolation with Laserballoon (catheter ablation)

Sponsors

CCB Cardioangiologisches Centrum Bethanien, Markus Krankenhaus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - Paroxysmal and persistent atrial fibrillation with an episode duration of > 7 days and 48 h after atrial fibrillation episode onset - Ineffective treatment with at least one antiarrhythmic drug (class I-III) or betablocker - Age 18 - 80 years - Left atrial size 45 % - Patient is able to provide informed consent

Exclusion criteria

Exclusion criteria: - Contraindications for pulmonary vein isolation - Previous pulmonary vein isolation attempts - Inability to be treated with oral anticoagulation - Presence of intracardiac thrombi - Pregnancy - Participation in other clinical studies - Mitral regurgitation = III° - Moderate mitral stenosis - Unwilling to follow the study protocol and to attend follow-up visits

Design outcomes

Primary

MeasureTime frame
Documented (ECG and CRF (90-days-, 180-days-, 360-days-Follow Up)) recurrence of atrial fibrillation or any atrial tachyarrhythmia lasting > 30 seconds between day 90 and 365 after the index procedure.

Secondary

MeasureTime frame
- Incidence of peri-procedural complications such as: major bleeding requiring intervention, phrenic nerve palsy, pericardial tamponade, thromboembolic events, death - Number of gaps in the ablation line during the repeat procedure - Multiple procedure success rate

Countries

Germany

Contacts

Public ContactInes Timmermanns

CCB Cardioangiologisches Centrum Bethanien, Markus Krankenhaus

i.timmermanns@ccb.de0049 69 945028 146

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026